Sign In
Buy LLY
$1,231.58
+45.87 (+3.87%)
At Close: Aug 10, 2026
Has This Top Pharma Company Found Its Next Billion-Dollar Product?
02:53pm, Thursday, 22'nd Dec 2022 The Motley Fool
Eli LIlly is looking to make waves in an important therapeutic area.
Roche (RHHBY) Actemra Gets FDA Nod for Adults With COVID-19
01:52pm, Thursday, 22'nd Dec 2022 Zacks Investment Research
Roche (RHHBY) obtains FDA approval for Actemra (tocilizumab) intravenous (IV) for the treatment of COVID-19 in hospitalized adult patients. The drug was earlier granted an EUA.
Has This Top Pharma Company Found Its Next Billion-Dollar Product?
09:53am, Thursday, 22'nd Dec 2022
Eli LIlly is looking to make waves in an important therapeutic area.
ProQR's stock jumps on expanded RNA deal with Lilly
09:12am, Thursday, 22'nd Dec 2022
Shares of ProQR Therapeutics NV PRQR, +1.85% soared 56.3% in premarket trading on Thursday after the company said it expanded an RNA editing deal with Eli Lilly & Co. Inc. LLY, +2.33% aimed at making
3 Drug Stocks Most Wall Street Analysts Are Bullish About
02:51pm, Wednesday, 21'st Dec 2022 Zacks Investment Research
Here we present three drug and biotech stocks, UTHR, ITCI and IMCR, which most analysts on Wall Street are optimistic about. These companies have upside potential for 2023 despite an uncertain macro e
Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says
08:00pm, Tuesday, 20'th Dec 2022 Benzinga
Madrigal Pharmaceuticals Inc (NASDAQ: MDGL) has announced positive topline results from the pivotal Phase 3 MAESTRO-NASH biopsy trial of resmetirom.
JMP has raised the price target from $182 to $31
Jim Cramer says these 7 stocks will be winners in 2023
06:31pm, Tuesday, 20'th Dec 2022
Cramer said many of Wall Street's concerns about the market are overblown.
Wall Street Analysts Think Lilly (LLY) Is a Good Investment: Is It?
02:30pm, Tuesday, 20'th Dec 2022 Zacks Investment Research
Based on the average brokerage recommendation (ABR), Lilly (LLY) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this hig
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
11:20am, Tuesday, 20'th Dec 2022 Zacks Investment Research
Sector ETF report for PPH
Eli Lilly (LLY) Stock Moves -0.58%: What You Should Know
10:45pm, Monday, 19'th Dec 2022 Zacks Investment Research
In the latest trading session, Eli Lilly (LLY) closed at $357.78, marking a -0.58% move from the previous day.
Eli Lilly Expects Enduring Growth, Despite Immediate Challenges
01:35pm, Monday, 19'th Dec 2022
Eli Lilly & Co may be struggling with supply-side issues but new partnerships and a healthy dividend are helping to keep up their momentum
The 7 Best Retirement Stocks to Buy Now
04:34pm, Sunday, 18'th Dec 2022
The best retirement stocks are easy enough to find if you take the time to look. While it still is a challenging time to invest if you have a short time horizon, for investors with longer time horizon
The 7 Hottest Healthcare Stocks to Own for 2023 and Beyond
09:04am, Sunday, 18'th Dec 2022
Major indices such as the S&P 500 and the Nasdaq Composite may have plunged by double-digits during 2022, but certain areas of the stock market performed strongly throughout the year. One of those
This momentum-stock strategy can be a winner regardless of whether the Federal Reserve pivots
12:41pm, Saturday, 17'th Dec 2022 MarketWatch
A strategy of holding stocks that have been on an upswing has outperformed the S&P 500 over the long term.
Time to Buy Eli Lilly (LLY) and AbbVie (ABBV) Stock for 2023?
01:20am, Saturday, 17'th Dec 2022 Zacks Investment Research
AbbVie's valuation, in particular, makes it a potentially strong candidate for 2023, while Eli Lilly's growth could support its stock next year.
